Correlation Between Genmab AS and NovaBay Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Genmab AS and NovaBay Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and NovaBay Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and NovaBay Pharmaceuticals, you can compare the effects of market volatilities on Genmab AS and NovaBay Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of NovaBay Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and NovaBay Pharmaceuticals.
Diversification Opportunities for Genmab AS and NovaBay Pharmaceuticals
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Genmab and NovaBay is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and NovaBay Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NovaBay Pharmaceuticals and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with NovaBay Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NovaBay Pharmaceuticals has no effect on the direction of Genmab AS i.e., Genmab AS and NovaBay Pharmaceuticals go up and down completely randomly.
Pair Corralation between Genmab AS and NovaBay Pharmaceuticals
Given the investment horizon of 90 days Genmab AS is expected to under-perform the NovaBay Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Genmab AS is 4.05 times less risky than NovaBay Pharmaceuticals. The stock trades about -0.3 of its potential returns per unit of risk. The NovaBay Pharmaceuticals is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 55.00 in NovaBay Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 6.00 from holding NovaBay Pharmaceuticals or generate 10.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Genmab AS vs. NovaBay Pharmaceuticals
Performance |
| Timeline |
| Genmab AS |
| NovaBay Pharmaceuticals |
Genmab AS and NovaBay Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Genmab AS and NovaBay Pharmaceuticals
The main advantage of trading using opposite Genmab AS and NovaBay Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, NovaBay Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NovaBay Pharmaceuticals will offset losses from the drop in NovaBay Pharmaceuticals' long position.| Genmab AS vs. Ascendis Pharma AS | Genmab AS vs. Apellis Pharmaceuticals | Genmab AS vs. BeiGene | Genmab AS vs. Akero Therapeutics |
| NovaBay Pharmaceuticals vs. Immix Biopharma | NovaBay Pharmaceuticals vs. Cns Pharmaceuticals | NovaBay Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | NovaBay Pharmaceuticals vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |